Lung Cancer Clinical Trials in Beijing, Beijing Municipality
19 recruitingBeijing, Beijing Municipality, China
Showing 1–19 of 19 trials
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Lung CancerPancreas CancerThyroid Cancer+1 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Research on Early Screening and Diagnosis of Pulmonary Nodules Based on Novel Non-invasive Technologies.
Lung Cancer
Chen KeZhong1,800 enrolled1 locationNCT07370077
Recruiting
Phase 1Phase 2
A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
Lung CancerStomach Cancer
3H Pharmaceuticals Co., Ltd.170 enrolled1 locationNCT07354711
Recruiting
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
Lung CancerPulmonary Nodules, SolitaryPulmonary Nodules, Multiple
ChromX Health3,000 enrolled15 locationsNCT06518655
Recruiting
Phase 1Phase 2
LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer
Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences60 enrolled1 locationNCT05886439
Recruiting
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences20,000 enrolled1 locationNCT06483698
Recruiting
Not Applicable
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
SurgeryLung CancerBlood Pressure Management+3 more
Peking University First Hospital1,988 enrolled1 locationNCT04209218
Recruiting
The Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy
Lung Cancer
China-Japan Friendship Hospital500 enrolled2 locationsNCT06692972
Recruiting
Not Applicable
Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients with Advanced Lung Cancer
Lung CancerAdult
Grit Biotechnology40 enrolled2 locationsNCT06519669
Recruiting
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
Lung CancerAdvanced Hepatocellular CarcinomaOligometastasis+2 more
Sun Yat-sen University470 enrolled1 locationNCT06644430
Recruiting
Phase 1Phase 2
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
Lung CancerLung Cancer Metastatic
Essen Biotech85 enrolled1 locationNCT06538012
Recruiting
The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer Patients
Lung CancerPostoperative Pain
Peking University People's Hospital100 enrolled1 locationNCT06503432
Recruiting
Observation on the Frailty Status of Lung Cancer Patients
Lung Cancer
Peking University Third Hospital200 enrolled1 locationNCT06448455
Recruiting
Phase 2
A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.
Lung Cancer
Jinghui Wang30 enrolled1 locationNCT06421298
Recruiting
Not Applicable
Comparing Valve-regulated Pleural Drainage to Traditional Closed Chest Tube Drainage
Lung Cancer
Peking Union Medical College Hospital100 enrolled1 locationNCT06410716
Recruiting
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer
Lung Cancer
Singlera Genomics Inc.600 enrolled1 locationNCT05432128
Recruiting
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Breast CancerLung Cancer
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy
Liver CancerPancreatic CancerLung Cancer+1 more
Peking University Third Hospital57 enrolled1 locationNCT06342323
Recruiting
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Lung CancerLung AdenocarcinomaLung Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences60,000 enrolled1 locationNCT06255197